A novel peptide agonist of galanin receptors reduces doxorubicin-induced heart failure in rats

被引：0
|
作者：
Lyubimov, R. O. [1 ]
Studneva, I. M. [1 ]
Palkeeva, M. E. [1 ]
Molokoedov, A. A. [1 ]
Prosvirnin, A. V. [1 ]
Veselova, O. M. [1 ]
Ovchinnikov, M. V. [1 ]
Eddin, O. A. Mokhi [1 ]
Sidorova, M. V. [1 ]
Pisarenko, O. I. [1 ]
机构：
[1] Natl Med Res Ctr Cardiol, Moscow, Russia
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1863
引用
收藏
页码：473 / 473
页数：1
相关论文
共 50 条
  • [31] Oxidative Stress and Pyroptosis in Doxorubicin-Induced Heart Failure and Atrial Fibrillation
    Ping Z.
    Fangfang T.
    Yuliang Z.
    Xinyong C.
    Lang H.
    Fan H.
    Jun M.
    Liang S.
    Oxidative Medicine and Cellular Longevity, 2023, 2023
  • [32] Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure
    Tallaj, JA
    Franco, V
    Rayburn, BK
    Pinderski, L
    Benza, RL
    Pamboukian, S
    Foley, B
    Bourge, RC
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (12): : 2196 - 2201
  • [33] Periplocymarin Alleviates Doxorubicin-Induced Heart Failure and Excessive Accumulation of Ceramides
    Yun, Weijing
    Qian, Lei
    Yuan, Ruqiang
    Xu, Hu
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [34] Prevention of Chronic Doxorubicin-Induced Heart Failure and Cardiotoxicity by Resveratrol Treatment
    Danz, Elizabeth D. Brookins
    Gasiewicz, Jillian
    Keller, Rebecca S.
    CIRCULATION RESEARCH, 2009, 105 (07) : E37 - E37
  • [35] Chimeric Agonist of Galanin Receptor GALR2 Reduces Heart Damage in Rats with Streptozotocin-Induced Diabetes
    Studneva, Irina M.
    Veselova, Oksana M.
    Dobrokhotov, Igor, V
    Serebryakova, Larisa, I
    Palkeeva, Marina E.
    Molokoedov, Alexander S.
    Azmuko, Andrey A.
    Ovchinnikov, Michael, V
    Sidorova, Maria, V
    Pisarenko, Oleg, I
    BIOCHEMISTRY-MOSCOW, 2022, 87 (04) : 346 - 355
  • [36] LongShengZhi capsule inhibits doxorubicin-induced heart failure by antioxidative stress
    Xu, Shuai
    Wang, Yuanyu
    Yu, Maoyun
    Wang, Dandan
    Liang, Yingquan
    Chen, Yuanli
    Liao, Chenzhong
    Xie, Zhouling
    Zhao, Buchang
    Han, Jihong
    Duan, Yajun
    Yang, Xiaoxiao
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 123
  • [37] RISK-FACTORS FOR DOXORUBICIN-INDUCED CONGESTIVE HEART-FAILURE
    VONHOFF, DD
    LAYARD, MW
    BASA, P
    DAVIS, HL
    VONHOFF, AL
    ROZENCWEIG, M
    MUGGIA, FM
    ANNALS OF INTERNAL MEDICINE, 1979, 91 (05) : 710 - 717
  • [38] Cardioprotective Effects of Mebudipine in a Rat Model of Doxorubicin-Induced Heart Failure
    Aali, Ehsan
    Ghaznavi, Habib
    Soltanpour, Mohammad Soleiman
    Mahmoudian, Massoud
    Shafiei, Massoumeh
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2021, 46 (02) : 136 - 143
  • [39] Can cellular transplantation improve function in doxorubicin-induced heart failure?
    Scorsin, M
    Hagege, AA
    Dolizy, I
    Marotte, F
    Mirochnik, N
    Copin, H
    Barnoux, M
    le Bert, M
    Samuel, JL
    Rappaport, L
    Menasche, P
    CIRCULATION, 1998, 98 (19) : II151 - II155
  • [40] Arginase inhibition retards the development of doxorubicin-induced heart failure in mice
    Toya, T.
    Hakuno, D.
    Kujiraoka, T.
    Adachi, T.
    EUROPEAN HEART JOURNAL, 2012, 33 : 1048 - 1049
12345